Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas.
The Peptide Based Gastrointestinal Disorders Therapeutics is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Peptide Based Gastrointestinal Disorders Therapeutics market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.
A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Peptide Based Gastrointestinal Disorders Therapeutics industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.
The Snapshot of Global Peptide Based Gastrointestinal Disorders Therapeutics Market Segmentations:
By Players:
NPS Pharmaceuticals, Inc
Allergan plc
Ironwood Pharmaceuticals, Inc
Astellas Pharma Inc
Synergy Pharmaceuticals Inc
Cipher Pharmaceuticals Inc
By Types:
Teduglutide
Linaclotide
Others
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Regions:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
France
-
Italy
-
Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)
-
Spain
-
Belgium
-
Poland
-
Russia
-
Turkey
-
Others
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Australia and New Zealand
-
ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)
Latin America, Middle East & Africa
-
GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)
-
Brazil
-
Nigeria
-
South Africa
-
Argentina
-
Others
Table of Contents
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Peptide Based Gastrointestinal Disorders Therapeutics Market
-
1.3 Market Segmentation by Type
-
1.3.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate of Teduglutide from 2014 to 2026
-
1.3.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate of Linaclotide from 2014 to 2026
-
1.3.3 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate of Others from 2014 to 2026
-
1.4 Market Segmentation by End-Users
-
1.4.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026
-
1.4.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026
-
1.4.3 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate of Online Pharmacies from 2014 to 2026
-
1.5 Market Segmentation by Regions
-
1.5.1 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate from 2014 to 2026
-
1.5.1.1 United States Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate from 2014 to 2026
-
1.5.1.2 Canada Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate from 2014 to 2026
-
1.5.1.3 Mexico Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate from 2014 to 2026
-
1.5.2.1 Germany Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate from 2014 to 2026
-
1.5.2.2 UK Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate from 2014 to 2026
-
1.5.2.3 France Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate from 2014 to 2026
-
1.5.2.4 Italy Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate from 2014 to 2026
-
1.5.2.5 Nordic Countries Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate from 2014 to 2026
-
1.5.2.6 Spain Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate from 2014 to 2026
-
1.5.2.7 Belgium Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate from 2014 to 2026
-
1.5.2.8 Poland Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate from 2014 to 2026
-
1.5.2.9 Russia Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate from 2014 to 2026
-
1.5.2.10 Turkey Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate from 2014 to 2026
-
1.5.3.1 China Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate from 2014 to 2026
-
1.5.3.2 Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate from 2014 to 2026
-
1.5.3.3 Australia and New Zealand Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate from 2014 to 2026
-
1.5.3.4 India Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate from 2014 to 2026
-
1.5.3.5 ASEAN Countries Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate from 2014 to 2026
-
1.5.3.6 South Korea Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Latin America, Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate from 2014 to 2026
-
1.5.4.1 GCC Countries Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate from 2014 to 2026
-
1.5.4.2 Brazil Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate from 2014 to 2026
-
1.5.4.3 Nigeria Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate from 2014 to 2026
-
1.5.4.4 South Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate from 2014 to 2026
-
1.5.4.5 Argentina Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Peptide Based Gastrointestinal Disorders Therapeutics Market by Types
-
3.1 Product Development Trends of Different Types
-
3.2 Commercial Product Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Peptide Based Gastrointestinal Disorders Therapeutics by Major Types
-
3.4.1 Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate of Teduglutide
-
3.4.2 Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate of Linaclotide
-
3.4.3 Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate of Others
4 Segmentation of Peptide Based Gastrointestinal Disorders Therapeutics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Peptide Based Gastrointestinal Disorders Therapeutics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Peptide Based Gastrointestinal Disorders Therapeutics in Hospital Pharmacies
-
4.4.2 Market Size and Growth Rate of Peptide Based Gastrointestinal Disorders Therapeutics in Retail Pharmacies
-
4.4.3 Market Size and Growth Rate of Peptide Based Gastrointestinal Disorders Therapeutics in Online Pharmacies
5 Market Analysis by Major Regions
-
5.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Production Analysis by Major Regions
-
5.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Consumption Analysis by Major Regions
-
5.3 Global Peptide Based Gastrointestinal Disorders Therapeutics Production, Import, Consumption and Export Analysis by Regions
-
5.3.1 North America Peptide Based Gastrointestinal Disorders Therapeutics Production, Import, Consumption and Export Analysis
-
5.3.2 Europe Peptide Based Gastrointestinal Disorders Therapeutics Production, Import, Consumption and Export Analysis
-
5.3.3 Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Production, Import, Consumption and Export Analysis
-
5.3.4 Latin America, Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Production, Import, Consumption and Export Analysis
6 Product Commodity of Peptide Based Gastrointestinal Disorders Therapeutics Market in Major Countries
-
6.1 Top 5 Export Countries in Peptide Based Gastrointestinal Disorders Therapeutics market from 2014 to 2019
-
6.1.1 Top 5 Export Countries' Export Value Analysis in Peptide Based Gastrointestinal Disorders Therapeutics market from 2014 to 2019
-
6.1.2 Top 5 Export Countries' Export Volume Analysis in Peptide Based Gastrointestinal Disorders Therapeutics market from 2014 to 2019
-
6.2 Top 5 Import Countries in Peptide Based Gastrointestinal Disorders Therapeutics market from 2014 to 2019
-
6.2.1 Top 5 Import Countries' Import Value Analysis in Peptide Based Gastrointestinal Disorders Therapeutics market from 2014 to 2019
-
6.2.2 Top 5 Import Countries' Import Volume Analysis in Peptide Based Gastrointestinal Disorders Therapeutics market from 2014 to 2019
-
6.3 Emerging Top 3 Export Countries Analysis
-
6.4 Emerging Top 3 Import Countries Analysis
7 North America Peptide Based Gastrointestinal Disorders Therapeutics Landscape Analysis
-
7.1 North America Peptide Based Gastrointestinal Disorders Therapeutics Landscape Analysis by Major Types
-
7.2 North America Peptide Based Gastrointestinal Disorders Therapeutics Landscape Analysis by Major End-Users
-
7.3 North America Peptide Based Gastrointestinal Disorders Therapeutics Landscape Analysis by Major Countries
-
7.3.1 United States Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate
-
7.3.2 Canada Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate
-
7.3.3 Mexico Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate
8 Europe Peptide Based Gastrointestinal Disorders Therapeutics Landscape Analysis
-
8.1 Europe Peptide Based Gastrointestinal Disorders Therapeutics Landscape Analysis by Major Types
-
8.2 Europe Peptide Based Gastrointestinal Disorders Therapeutics Landscape Analysis by Major End-Users
-
8.3 Europe Peptide Based Gastrointestinal Disorders Therapeutics Landscape Analysis by Major Countries
-
8.3.1 Germany Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate
-
8.3.2 UK Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate
-
8.3.3 France Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate
-
8.3.4 Italy Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate
-
8.3.5 Nordic Countries Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate
-
8.3.6 Spain Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate
-
8.3.7 Belgium Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate
-
8.3.8 Poland Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate
-
8.3.9 Russia Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate
-
8.3.10 Turkey Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate
9 Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Landscape Analysis
-
9.1 Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Landscape Analysis by Major Types
-
9.2 Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Landscape Analysis by Major End-Users
-
9.3 Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Landscape Analysis by Major Countries
-
9.3.1 China Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate
-
9.3.2 Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate
-
9.3.3 Australia and New Zealand Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate
-
9.3.4 India Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate
-
9.3.5 ASEAN Countries Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate
-
9.3.6 South Korea Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate
10 Latin America, Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Landscape Analysis
-
10.1 Latin America, Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Landscape Analysis by Major Types
-
10.2 Latin America, Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Landscape Analysis by Major End-Users
-
10.3 Latin America, Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Landscape Analysis by Major Countries
-
10.3.1 GCC Countries Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate
-
10.3.2 Brazil Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate
-
10.3.3 Nigeria Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate
-
10.3.4 South Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate
-
10.3.5 Argentina Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate
11 Major Players Profile
-
11.1 NPS Pharmaceuticals, Inc
-
11.1.1 NPS Pharmaceuticals, Inc Company Profile and Recent Development
-
11.1.2 Market Performance
-
11.1.3 Product and Service Introduction
-
11.2 Allergan plc
-
11.2.1 Allergan plc Company Profile and Recent Development
-
11.2.2 Market Performance
-
11.2.3 Product and Service Introduction
-
11.3 Ironwood Pharmaceuticals, Inc
-
11.3.1 Ironwood Pharmaceuticals, Inc Company Profile and Recent Development
-
11.3.2 Market Performance
-
11.3.3 Product and Service Introduction
-
11.4 Astellas Pharma Inc
-
11.4.1 Astellas Pharma Inc Company Profile and Recent Development
-
11.4.2 Market Performance
-
11.4.3 Product and Service Introduction
-
11.5 Synergy Pharmaceuticals Inc
-
11.5.1 Synergy Pharmaceuticals Inc Company Profile and Recent Development
-
11.5.2 Market Performance
-
11.5.3 Product and Service Introduction
-
11.6 Cipher Pharmaceuticals Inc
-
11.6.1 Cipher Pharmaceuticals Inc Company Profile and Recent Development
-
11.6.2 Market Performance
-
11.6.3 Product and Service Introduction
12 Data Source and Research Methodology
The List of Tables and Figures (Totals 87 Figures and 141 Tables)
-
Figure Product Picture
-
Figure Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate of Teduglutide from 2014 to 2026
-
Figure Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate of Linaclotide from 2014 to 2026
-
Figure Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate of Others from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
-
Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026
-
Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026
-
Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate of Online Pharmacies from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure North America Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure United States Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Canada Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Mexico Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Europe Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Germany Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure UK Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure France Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Italy Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Nordic Countries Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Spain Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Belgium Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Poland Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Russia Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Turkey Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure China Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Japan Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Australia and New Zealand Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure India Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure ASEAN Countries Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure South Korea Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Latin America, Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure GCC Countries Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Brazil Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Nigeria Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure South Africa Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Argentina Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Peptide Based Gastrointestinal Disorders Therapeutics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Peptide Based Gastrointestinal Disorders Therapeutics
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Peptide Based Gastrointestinal Disorders Therapeutics by Different Types from 2014 to 2026
-
Table Consumption Share of Peptide Based Gastrointestinal Disorders Therapeutics by Different Types from 2014 to 2026
-
Figure Market Size and Growth Rate of Teduglutide
-
Figure Market Size and Growth Rate of Linaclotide
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Peptide Based Gastrointestinal Disorders Therapeutics by Different End-Users from 2014 to 2026
-
Table Consumption Share of Peptide Based Gastrointestinal Disorders Therapeutics by Different End-Users from 2014 to 2026
-
Figure Market Size and Growth Rate of Hospital Pharmacies
-
Figure Market Size and Growth Rate of Retail Pharmacies
-
Figure Market Size and Growth Rate of Online Pharmacies
-
Table Global Peptide Based Gastrointestinal Disorders Therapeutics Production by Major Regions
-
Table Global Peptide Based Gastrointestinal Disorders Therapeutics Production Share by Major Regions
-
Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Production Share by Major Regions in 2014
-
Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Production Share by Major Regions in 2018
-
Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Production Share by Major Regions in 2026
-
Table Global Peptide Based Gastrointestinal Disorders Therapeutics Consumption by Major Regions
-
Table Global Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Major Regions
-
Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Major Regions in 2014
-
Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Major Regions in 2018
-
Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Major Regions in 2026
-
Table North America Peptide Based Gastrointestinal Disorders Therapeutics Production, Import, Consumption and Export Analysis
-
Table Europe Peptide Based Gastrointestinal Disorders Therapeutics Production, Import, Consumption and Export Analysis
-
Table Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Production, Import, Consumption and Export Analysis
-
Table Latin America, Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Production, Import, Consumption and Export Analysis
-
Table Top 5 Export Countries' Export Value Analysis in Peptide Based Gastrointestinal Disorders Therapeutics market from 2014 to 2019
-
Table Top 5 Export Countries' Export Volume Analysis in Peptide Based Gastrointestinal Disorders Therapeutics market from 2014 to 2019
-
Table Top 5 Import Countries' Import Value Analysis in Peptide Based Gastrointestinal Disorders Therapeutics market from 2014 to 2019
-
Table Top 5 Import Countries' Import Volume Analysis in Peptide Based Gastrointestinal Disorders Therapeutics market from 2014 to 2019
-
Figure Emerging Top 3 Export Countries Analysis
-
Figure Emerging Top 3 Import Countries Analysis
-
Table North America Peptide Based Gastrointestinal Disorders Therapeutics Consumption by Types from 2014 to 2026
-
Table North America Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Types from 2014 to 2026
-
Figure North America Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Types in 2014
-
Figure North America Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Types in 2018
-
Figure North America Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Types in 2026
-
Table North America Peptide Based Gastrointestinal Disorders Therapeutics Consumption by End-Users from 2014 to 2026
-
Table North America Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Figure North America Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by End-Users in 2014
-
Figure North America Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by End-Users in 2018
-
Figure North America Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by End-Users in 2026
-
Table North America Peptide Based Gastrointestinal Disorders Therapeutics Consumption by Major Countries from 2014 to 2026
-
Table North America Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Major Countries from 2014 to 2026
-
Figure North America Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Major Countries in 2014
-
Figure North America Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Major Countries in 2018
-
Figure North America Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Major Countries in 2026
-
Figure United States Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Canada Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Mexico Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Table Europe Peptide Based Gastrointestinal Disorders Therapeutics Consumption by Types from 2014 to 2026
-
Table Europe Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Types from 2014 to 2026
-
Figure Europe Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Types in 2014
-
Figure Europe Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Types in 2018
-
Figure Europe Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Types in 2026
-
Table Europe Peptide Based Gastrointestinal Disorders Therapeutics Consumption by End-Users from 2014 to 2026
-
Table Europe Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Figure Europe Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by End-Users in 2014
-
Figure Europe Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by End-Users in 2018
-
Figure Europe Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by End-Users in 2026
-
Table Europe Peptide Based Gastrointestinal Disorders Therapeutics Consumption by Major Countries from 2014 to 2026
-
Table Europe Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Major Countries from 2014 to 2026
-
Figure Europe Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Major Countries in 2014
-
Figure Europe Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Major Countries in 2018
-
Figure Europe Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Major Countries in 2026
-
Figure Germany Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure UK Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure France Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Italy Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Nordic Countries Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Belgium Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Poland Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Russia Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Turkey Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Table Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Consumption by Types from 2014 to 2026
-
Table Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Types from 2014 to 2026
-
Figure Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Types in 2014
-
Figure Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Types in 2018
-
Figure Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Types in 2026
-
Table Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Consumption by End-Users from 2014 to 2026
-
Table Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Figure Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by End-Users in 2014
-
Figure Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by End-Users in 2018
-
Figure Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by End-Users in 2026
-
Table Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Consumption by Major Countries from 2014 to 2026
-
Table Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Major Countries from 2014 to 2026
-
Figure Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Major Countries in 2014
-
Figure Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Major Countries in 2018
-
Figure Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Major Countries in 2026
-
Figure China Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Australia and New ZealandPeptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure India Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure ASEAN Countries Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure South Korea Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Table Latin America, Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Consumption by Types from 2014 to 2026
-
Table Latin America, Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Types from 2014 to 2026
-
Figure Latin America, Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Types in 2014
-
Figure Latin America, Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Types in 2018
-
Figure Latin America, Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Types in 2026
-
Table Latin America, Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Consumption by End-Users from 2014 to 2026
-
Table Latin America, Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by End-Users from 2014 to 2026
-
Figure Latin America, Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by End-Users in 2014
-
Figure Latin America, Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by End-Users in 2018
-
Figure Latin America, Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by End-Users in 2026
-
Table Latin America, Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Consumption by Major Countries from 2014 to 2026
-
Table Latin America, Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Major Countries from 2014 to 2026
-
Figure Latin America, Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Major Countries in 2014
-
Figure Latin America, Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Major Countries in 2018
-
Figure Latin America, Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Consumption Share by Major Countries in 2026
-
Figure GCC Countries Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Brazil Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Nigeria Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure South Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Figure Argentina Peptide Based Gastrointestinal Disorders Therapeutics Market Volume and Growth Rate from 2014 to 2026
-
Table Company Profile and Development Status of NPS Pharmaceuticals, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of NPS Pharmaceuticals, Inc
-
Figure Sales and Growth Rate Analysis of NPS Pharmaceuticals, Inc
-
Figure Revenue and Market Share Analysis of NPS Pharmaceuticals, Inc
-
Table Product and Service Introduction of NPS Pharmaceuticals, Inc
-
Table Company Profile and Development Status of Allergan plc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan plc
-
Figure Sales and Growth Rate Analysis of Allergan plc
-
Figure Revenue and Market Share Analysis of Allergan plc
-
Table Product and Service Introduction of Allergan plc
-
Table Company Profile and Development Status of Ironwood Pharmaceuticals, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ironwood Pharmaceuticals, Inc
-
Figure Sales and Growth Rate Analysis of Ironwood Pharmaceuticals, Inc
-
Figure Revenue and Market Share Analysis of Ironwood Pharmaceuticals, Inc
-
Table Product and Service Introduction of Ironwood Pharmaceuticals, Inc
-
Table Company Profile and Development Status of Astellas Pharma Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma Inc
-
Figure Sales and Growth Rate Analysis of Astellas Pharma Inc
-
Figure Revenue and Market Share Analysis of Astellas Pharma Inc
-
Table Product and Service Introduction of Astellas Pharma Inc
-
Table Company Profile and Development Status of Synergy Pharmaceuticals Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Synergy Pharmaceuticals Inc
-
Figure Sales and Growth Rate Analysis of Synergy Pharmaceuticals Inc
-
Figure Revenue and Market Share Analysis of Synergy Pharmaceuticals Inc
-
Table Product and Service Introduction of Synergy Pharmaceuticals Inc
-
Table Company Profile and Development Status of Cipher Pharmaceuticals Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cipher Pharmaceuticals Inc
-
Figure Sales and Growth Rate Analysis of Cipher Pharmaceuticals Inc
-
Figure Revenue and Market Share Analysis of Cipher Pharmaceuticals Inc
-
Table Product and Service Introduction of Cipher Pharmaceuticals Inc
-
